Back to search

Article

Riluzole treatment paradoxically increases motoneuron excitability in ALS due to hyperactive homeostasis

2026-03-25

Abstract excerpt

<h4>ABSTRACT</h4> Riluzole is the most commonly prescribed among the limited approved therapies for amyotrophic lateral sclerosis (ALS), a neurodegenerative disorder characterized by progressive motoneuron loss and paralysis. It is thought to act by suppressing motoneuron excitability and glutamate release, but its clinical benefits are modest and often diminish over time. We previously showed that homeostatic me...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
96ae28fa-4c2b-5999-a500-aa0b21f0bf09
DOI
10.64898/2026.03.23.713695
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Riluzole treatment paradoxically increases motoneuron excitability in ALS due to hyperactive homeostasisDOI 10.64898/2026.03.23.713695
Select a neighboring publication to make it the new centre.